News
RVTY
112.56
+1.83%
2.02
UBS says ‘underweight the names with high China exposure’
Seeking Alpha · 2d ago
How To YieldBoost Revvity To 12.8% Using Options
NASDAQ · 3d ago
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching
Simply Wall St · 3d ago
Revvity’s Strategic Market Position and Anticipated Growth Drive Buy Rating
TipRanks · 4d ago
Weekly Report: what happened at RVTY last week (1209-1213)?
Weekly Report · 12/16 09:04
Safe Biopharma: Revvity's Recurring Revenues And Diagnostics
Seeking Alpha · 12/16 05:27
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
Benzinga · 12/13 18:57
Revvity Price Target Announced at $138.00/Share by B of A Securities
Dow Jones · 12/13 17:13
Revvity Raised to Buy From Neutral by B of A Securities
Dow Jones · 12/13 17:13
B of A Securities Upgrades Revvity to Buy, Announces $138 Price Target
Benzinga · 12/13 17:03
Weekly Report: what happened at RVTY last week (1202-1206)?
Weekly Report · 12/09 09:04
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Revvity (RVTY) and McKesson (MCK)
TipRanks · 12/06 06:01
Weekly Report: what happened at RVTY last week (1125-1129)?
Weekly Report · 12/02 09:04
Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)
Simply Wall St · 12/01 14:07
Janus Henderson Mid Cap Growth Managed Account Q3 2024 Commentary
Seeking Alpha · 11/29 08:20
Stifel Nicolaus Remains a Hold on Revvity (RVTY)
TipRanks · 11/28 07:45
We Did The Math XLV Can Go To $170
NASDAQ · 11/27 12:22
What Are Wall Street Analysts' Target Price for Revvity Stock?
Barchart · 11/26 07:39
Revvity Is Maintained at Overweight by Barclays
Dow Jones · 11/25 14:51
Revvity Price Target Cut to $135.00/Share From $140.00 by Barclays
Dow Jones · 11/25 14:51
More
Webull provides a variety of real-time RVTY stock news. You can receive the latest news about Revvity Inc through multiple platforms. This information may help you make smarter investment decisions.
About RVTY
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.